The Global Stents Market was valued at USD 10.1 billion in 2025 and is estimated to grow at a CAGR of 8.4% to reach USD 22.3 billion by 2035.
Market growth is driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, technological advancements in stent design, and expanding healthcare infrastructure in emerging regions. Stents are small, tubular medical devices that maintain the patency of narrowed or blocked blood vessels, ensuring consistent blood flow and preventing vessel collapse. The growing incidence of coronary artery disease, peripheral artery disease, and aneurysms, combined with lifestyle factors such as sedentary behavior, poor diet, and smoking, fuels demand for stent procedures. Innovations, including drug-eluting stents, bioresorbable stents, and biodegradable polymer coatings, enhance patient outcomes, reduce restenosis, and improve procedural safety. The market is further propelled by patient-centric solutions, digital health integration, and the development of smart stents, which collectively expand treatment options and adoption globally.
The vascular stents segment held a share of 93% in 2025, driven by the widespread prevalence of coronary artery disease and preference for minimally invasive cardiovascular interventions. Endovascular stenting is favored over open surgical bypass due to shorter recovery times, lower complication risks, and reduced hospital stays. Expansion of cardiovascular care centers, availability of trained specialists, and growing awareness of early detection, particularly in Asia-Pacific, Latin America, and the Middle East, contribute to increasing adoption of vascular stents.
The hospitals segment accounted for 73.6% share in 2025, reaching USD 16 billion. Hospitals are increasingly performing percutaneous coronary interventions and endovascular procedures, as stent implantation shortens recovery periods, reduces procedural risks, and improves patient throughput. The rising number of patients with cardiovascular conditions due to aging populations and lifestyle-related risk factors is driving higher demand for stents in both cardiac and peripheral interventions.
U.S. Stents Market reached USD 3.5 billion in 2025. The increasing prevalence of coronary artery disease and peripheral artery disease, combined with aging demographics and lifestyle-related risks such as obesity, hypertension, and diabetes, drives procedural volumes. The presence of advanced hospitals, specialized cardiac centers, and catheterization labs facilitates high-volume stent implantation. Insurance coverage and reimbursement policies in the U.S. and Canada also encourage patients to undergo both elective and emergency procedures, further supporting market growth.
Prominent players in the Global Stents Market include Abbott, Medtronic, Boston Scientific, Biotronik, MicroPort Scientific, Stryker, W.L Gore & Associates, B. Braun, Biosensors International Group, Terumo, Veryan Medical, Elixir Medical, Johnson & Johnson, and SLTL Group. Companies in the Global Stents Market strengthen their presence by focusing on continuous research and development to improve stent design, durability, and safety features. They are expanding production capacities, forming strategic partnerships with hospitals and healthcare providers, and entering emerging markets to reach underserved populations. Firms emphasize minimally invasive and patient-specific solutions, integrate digital health technologies with smart stents, and launch drug-eluting and bioresorbable products to enhance clinical outcomes. Marketing initiatives, training programs for clinicians, and collaborations with key cardiovascular centers help companies build brand trust, drive adoption, and maintain a competitive edge in the global market.
This product will be delivered within 2-4 business days.
Market growth is driven by the rising prevalence of cardiovascular diseases, increasing adoption of minimally invasive procedures, technological advancements in stent design, and expanding healthcare infrastructure in emerging regions. Stents are small, tubular medical devices that maintain the patency of narrowed or blocked blood vessels, ensuring consistent blood flow and preventing vessel collapse. The growing incidence of coronary artery disease, peripheral artery disease, and aneurysms, combined with lifestyle factors such as sedentary behavior, poor diet, and smoking, fuels demand for stent procedures. Innovations, including drug-eluting stents, bioresorbable stents, and biodegradable polymer coatings, enhance patient outcomes, reduce restenosis, and improve procedural safety. The market is further propelled by patient-centric solutions, digital health integration, and the development of smart stents, which collectively expand treatment options and adoption globally.
The vascular stents segment held a share of 93% in 2025, driven by the widespread prevalence of coronary artery disease and preference for minimally invasive cardiovascular interventions. Endovascular stenting is favored over open surgical bypass due to shorter recovery times, lower complication risks, and reduced hospital stays. Expansion of cardiovascular care centers, availability of trained specialists, and growing awareness of early detection, particularly in Asia-Pacific, Latin America, and the Middle East, contribute to increasing adoption of vascular stents.
The hospitals segment accounted for 73.6% share in 2025, reaching USD 16 billion. Hospitals are increasingly performing percutaneous coronary interventions and endovascular procedures, as stent implantation shortens recovery periods, reduces procedural risks, and improves patient throughput. The rising number of patients with cardiovascular conditions due to aging populations and lifestyle-related risk factors is driving higher demand for stents in both cardiac and peripheral interventions.
U.S. Stents Market reached USD 3.5 billion in 2025. The increasing prevalence of coronary artery disease and peripheral artery disease, combined with aging demographics and lifestyle-related risks such as obesity, hypertension, and diabetes, drives procedural volumes. The presence of advanced hospitals, specialized cardiac centers, and catheterization labs facilitates high-volume stent implantation. Insurance coverage and reimbursement policies in the U.S. and Canada also encourage patients to undergo both elective and emergency procedures, further supporting market growth.
Prominent players in the Global Stents Market include Abbott, Medtronic, Boston Scientific, Biotronik, MicroPort Scientific, Stryker, W.L Gore & Associates, B. Braun, Biosensors International Group, Terumo, Veryan Medical, Elixir Medical, Johnson & Johnson, and SLTL Group. Companies in the Global Stents Market strengthen their presence by focusing on continuous research and development to improve stent design, durability, and safety features. They are expanding production capacities, forming strategic partnerships with hospitals and healthcare providers, and entering emerging markets to reach underserved populations. Firms emphasize minimally invasive and patient-specific solutions, integrate digital health technologies with smart stents, and launch drug-eluting and bioresorbable products to enhance clinical outcomes. Marketing initiatives, training programs for clinicians, and collaborations with key cardiovascular centers help companies build brand trust, drive adoption, and maintain a competitive edge in the global market.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Research Methodology
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product, 2022-2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Material, 2022-2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Type, 2022-2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by End Use, 2022-2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2022-2035 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies profiled in this Stents market report include:- Abbott
- B. Braun
- Becton, Dickinson and Company
- Biosensors International Group
- Biotronik
- Boston Scientific
- Elixir Medical
- Medtronic
- Meril Life Science
- MicroPort Scientific
- SLTL Group
- Stryker
- Terumo
- Veryan Medical
- W.L Gore & Associates
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 135 |
| Published | March 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 10.1 Billion |
| Forecasted Market Value ( USD | $ 22.3 Billion |
| Compound Annual Growth Rate | 8.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
